Groups

Articles – recent additions

1. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen.

   Journal Article

   Hagen, P; D'Souza, A; Hari, P; Davila, O; Zhang, MJ; Vesole, DH; Smith, SE; Rodriguez, TE; Stiff, PJ
   Leukemia lymphoma (2020)

   Find It @ Loyola | Save
2. When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.

   Journal Article

   Gilmore, BA; Rodby, RA; Cimbaluk, D; Venugopal, P; Patel, P; Barton, K; Hagen, P; Rodriguez, T; Sumoza, L; Bishop, MR; more...
   Clinical lymphoma, myeloma leukemia (2019)

   Find It @ Loyola | Save
3. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

   Journal Article

   Richardson, P. G.; Riches, M. L.; Kernan, N. A.; Brochstein, J. A.; Mineishi, S.; Termuhlen, A. M.; Arai, S.; Grupp, S. A.; Guinan, E. C.; Martin, P. L.; more...
   Blood (2016)

   Find It @ Loyola | Save